APA (7th ed.) Citation

H, W., ESM, N., P, A., R, K., DO, S., S, S., . . . JR, S. (2025). The effect of modified donanemab titration on amyloid-related imaging abnormalities with edema/effusions and amyloid reduction: 18-month results from TRAILBLAZER-ALZ 6. The journal of prevention of Alzheimer's disease, 12(8), 100266. https://doi.org/10.1016/j.tjpad.2025.100266

Chicago Style (17th ed.) Citation

H, Wang, et al. "The Effect of Modified Donanemab Titration on Amyloid-related Imaging Abnormalities with Edema/effusions and Amyloid Reduction: 18-month Results from TRAILBLAZER-ALZ 6." The Journal of Prevention of Alzheimer's Disease 12, no. 8 (2025): 100266. https://doi.org/10.1016/j.tjpad.2025.100266.

MLA (9th ed.) Citation

H, Wang, et al. "The Effect of Modified Donanemab Titration on Amyloid-related Imaging Abnormalities with Edema/effusions and Amyloid Reduction: 18-month Results from TRAILBLAZER-ALZ 6." The Journal of Prevention of Alzheimer's Disease, vol. 12, no. 8, 2025, p. 100266, https://doi.org/10.1016/j.tjpad.2025.100266.